HAVELKA, David, Hana PŘIKRYLOVÁ KUČEROVÁ, Radovan PŘIKRYL and Eva ČEŠKOVÁ. Cognitive impairment and cortisol levels in first-episode schizophrenia patients. Stress : The International Journal on the Biology of Stress. Taylor&Francis, vol. 19, No 4, p. 383-389. ISSN 1025-3890. doi:10.1080/10253890.2016.1193146. 2016.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Cognitive impairment and cortisol levels in first-episode schizophrenia patients
Authors HAVELKA, David (203 Czech Republic, guarantor, belonging to the institution), Hana PŘIKRYLOVÁ KUČEROVÁ (203 Czech Republic, belonging to the institution), Radovan PŘIKRYL (203 Czech Republic, belonging to the institution) and Eva ČEŠKOVÁ (203 Czech Republic, belonging to the institution).
Edition Stress : The International Journal on the Biology of Stress, Taylor&Francis, 2016, 1025-3890.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 50100 5.1 Psychology and cognitive sciences
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 2.590
RIV identification code RIV/00216224:14210/16:00090364
Organization unit Faculty of Arts
Doi http://dx.doi.org/10.1080/10253890.2016.1193146
UT WoS 000382518400006
Keywords in English Cognitive impairment; dexamethasone suppression test; first-episode schizophrenia; memory functions; plasma afternoon cortisol levels; plasma post-dexamethasone cortisol levels
Tags rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Vojtěch Juřík, Ph.D., učo 372092. Changed: 20/1/2019 20:49.
Abstract
Many modalities of cognition are affected in schizophrenia. The most common findings include dysfunctions of episodic and working memory and of executive functions. Although an inverse correlation between cortisol level and memory function has been proven, few studies have focused on the relationship between cortisol level and cognitive impairment in patients with schizophrenia. In an open, naturalistic, prospectivestudy, consecutively hospitalized males diagnosed with first-episode schizophrenia, hypothalamic–pituitary–adrenal axis activity (afternoon cortisol levels, post-dexamethasone cortisol levels) was evaluated before and at the end of acute treatment. Psychopathology was assessed using the positive and negative syndrome scale (PANSS). Cognitive functions (memory, attention, psychomotor, verbal fluency, and executive functions) were tested after symptom alleviation using a neurocognitive test battery. In the total sample (n=23), significant decreases in total PANSS score (including all subscales), afternoon cortisol levels, and post-dexamethasone cortisol levels occurred during the course of treatment. It was found that higher afternoon cortisol levels at the beginning of treatment were significantly related to impaired performance in memory functions. Afternoon cortisol levels were not significantly associated with other measured cognitive functions. No correlation was discovered between cognitive functions and post-dexamethasone cortisol levels. The determination of afternoon cortisol levels may serve to detect potential candidates for specific cognitive intervention immediately after the first psychotic breakthrough.
Links
ED1.1.00/02.0068, research and development projectName: CEITEC - central european institute of technology
PrintDisplayed: 19/4/2024 15:05